Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hyman

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
British Journal of Pharmacology|December 2, 2022
Improved PIEZO1 agonism through 4-benzoic acid modification of Yoda1Gregory Parsonage, Kevin Cuthbertson, Naima Endesh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735Stephen Jones, Frankie Ann Holmes, Joyce O'Shaughnessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancerStephen E Jones, Michael A Savin, Frankie Ann Holmes, et al.
Oncotarget|February 9, 2017
Upregulated WEE1 protects endothelial cells of colorectal cancer liver metastasesPeter J Webster, Anna T Littlejohns, Hannah J Gaunt, et al.
Nature|August 15, 2014
Piezo1 integration of vascular architecture with physiological forceJing Li, Bing Hou, Sarka Tumova, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2004
Genome sequence of the enterobacterial phytopathogen Erwinia carotovora subsp. atroseptica and characterization of virulence factorsK S Bell, M Sebaihia, L Pritchard, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2016
Research Needs to Improve Hypertension Treatment and Control in African AmericansPaul K Whelton, Paula T Einhorn, Paul Muntner, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
British Journal of Pharmacology|December 2, 2022
Improved PIEZO1 agonism through 4-benzoic acid modification of Yoda1Gregory Parsonage, Kevin Cuthbertson, Naima Endesh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735Stephen Jones, Frankie Ann Holmes, Joyce O'Shaughnessy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancerStephen E Jones, Michael A Savin, Frankie Ann Holmes, et al.
Oncotarget|February 9, 2017
Upregulated WEE1 protects endothelial cells of colorectal cancer liver metastasesPeter J Webster, Anna T Littlejohns, Hannah J Gaunt, et al.
Nature|August 15, 2014
Piezo1 integration of vascular architecture with physiological forceJing Li, Bing Hou, Sarka Tumova, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2004
Genome sequence of the enterobacterial phytopathogen Erwinia carotovora subsp. atroseptica and characterization of virulence factorsK S Bell, M Sebaihia, L Pritchard, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2016
Research Needs to Improve Hypertension Treatment and Control in African AmericansPaul K Whelton, Paula T Einhorn, Paul Muntner, et al.
Pageof 21